Medications in FDA's National Priority Voucher Program
Nine medications are part of the initial list of program participants.
The FDA announced the first nine companies to participate in its National Priority Voucher program.
The program aims to promote novel treatments that benefit the health interests of Americans, including medications that meet a large, unmet need or reduce downstream health care utilization.
Medications using MFN pricing can also be considered for the program.
Author's summary: FDA's National Priority Voucher Program promotes novel treatments.